After a dreadful 2024 that saw its stock lose more than 60% of its value, 2025 has started off as a better year for Walgreens ...

Salesforce’s growth story remains compelling, with projected revenue growth of 17% in 2025 and strong demand for AI-driven ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elevance Health (ELV – Research Report), Intuitive Surgical ...

Rite Aid filed for (and emerged from) bankruptcy, and while its larger rivals aren't in as dire shape, they aren't exactly flourishing. Walgreens has lost a mammoth 77% of its value over the past ...

The S&P 500 (\^GSPC 0.88%) has been on fire for the last two years, racking up a gain of nearly 51%, which it hadn't done ...

Tesla falls on Trump’s plans to roll back EV production targets, Apple gets a downgrade, and 3M and Charles Schwab score ...

Walgreens Boots Alliance (NASDAQ: WBA), better known as Walgreens, was one of the worst-performing stocks of 2024. Although the S&P 500 index rose by more than 20% for the year, Walgreens dropped by a ...

We recently published a list of 10 Stocks Nosedive, Defying Broader Optimism. In this article, we are going to take a look at ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine. The financial package will fund the expansion of ...

Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had [recently bought another $1.1 billion of bitc ...

Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.